title: [Chronic inflammatory demyelinating polyradiculoneuropathy in childhood: outcomes after methylprednisolone pulse therapy].
abstract: BACKGROUND
  Chronic inflammatory demyelinating polyneuropathy (CIDP) in children is relatively rare and treatment is based primarily on intravenous immunoglobulins or oral corticosteroids. Boluses of methylprednisolone (MP) are a seldom used alternative.
  
  
  METHODS
  We report the case of an 8-year-old child, first presented at the age of 3 years, with recurring episodes of functional impotence of both lower limbs and walking impairment, partially reversible without treatment. Clinical, progressive, and electrophysiological data and the analysis of the cerebrospinal fluid were compatible with CIDP. MP boluses were administered: after a total eight monthly boluses, very satisfactory progression on the clinical and electrophysiological fronts was noted after 24 months.
  
  
  CONCLUSIONS
  Childhood CIDP presents clinical, electrophysiological, progressive, and prognostic particularities, they recur readily and the outcome is good. Boluses of methylprednisolone are an alternative to the treatment of these neuropathies in childhood.
authors.affiliation: Service de Neurologie - Explorations Fonctionnelles, Pavillon 30, CHU Ibn Rochd, Casablanca, Maroc. mo.mi2@caramail.com
authors.forename: M A
authors.initials: MA
authors.lastname: Rafai
authors.forename: F
authors.initials: F
authors.lastname: Moutaouakil
authors.forename: H
authors.initials: H
authors.lastname: El Otmani
authors.forename: H
authors.initials: H
authors.lastname: Fadel
authors.forename: F Z
authors.initials: FZ
authors.lastname: Boulaajaj
authors.forename: B
authors.initials: B
authors.lastname: El Moutawakil
authors.forename: I
authors.initials: I
authors.lastname: Gam
authors.forename: I
authors.initials: I
authors.lastname: Slassi
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D004576:Electromyography; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D009431:Neural Conduction / Q000502:physiology; D010525:Peripheral Nerves / Q000503:physiopathology; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D012008:Recurrence; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone